The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 155-162

  Chappell, Daniel ^a   Westphal, Martin ^b   Jacob, Matthias ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Endothelium; Glycocalyx; Microcirculation; Oxygen distribution; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBIN; ANTITHROMBIN III; ETANERCEPT; GLUCOCORTICOID; HYDROCORTISONE; HYPERTENSIVE FACTOR;

ADVERSE OUTCOME; BLOOD VESSEL PERMEABILITY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; EDEMA; FLUID RESUSCITATION; GLYCOCALYX; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOVOLEMIA; INTERSTITIAL FLUID; ISCHEMIA; MICROANGIOPATHY; MICROCIRCULATION; MORTALITY; NONHUMAN; OXYGEN CONCENTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY EFFECT; TISSUE OXYGENATION; VASCULAR ENDOTHELIUM;

CAPILLARY LEAK SYNDROME; CRITICAL ILLNESS; FLUID THERAPY; GLYCOCALYX; HUMANS; MICROCIRCULATION; OXYGEN; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 68049108421     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328328d1b6     Document Type: Review

References (61)

1. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26 (Suppl 1):S64-S74.
2. Aduen J, Bernstein WK, Khastgir T, et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA 1994; 272:1678-1685.
3. Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970; 41:989-1001.
4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl JMed 2001; 345:1368-1377.
5. Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35:2016-2024.
6. Marsden PA, Ballermann BJ. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 1990; 172:1843-1852.
7. Marx G. Fluid therapy in sepsis with capillary leakage. Eur J Anaesthesiol 2003; 20:429-442.
8. Boldt J. Volume therapy in the intensive care patient: we are still confused, but. . .. Intensive Care Med 2000; 26:1181-1192.
9. Trzeciak S, Cinel I, Dellinger RP, et al. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15:399-413. The authors explain the central role of microcirculation in the pathophysiology of sepsis; andelucidate new translational research techniques of in-vivo video microscopy for assessing microcirculation.
10. Astiz ME, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995; 23:265-271.
11. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004; 8:462-468.
12. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997; 110:87-95.
13. Fink MP. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001; 17:219-237.
14. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002; 30:1686-1692.
15. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60. The most recent guidelines for the treatment of sepsis summarize the entire clinical knowledge in this field.
16. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
17. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
18. Costa EL, Schettino IA, Schettino GP. The lung in sepsis: guilty or innocent? Endocr Metab Immune Disord Drug Targets 2006; 6:213-216.
19. Hollenberg SM, Guglielmi M, Parrillo JE. Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice. Crit Care 2007; 11:R125.
20. Groeneveld AB, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery 1986; 99:140-153.
21. Starling E. On the absorption of fluid from the connective tissue spaces. J Physiol (Lond) 1896; 19:312-326.
22. Chappell D, Jacob M, Becker BF, et al. Expedition glycocalyx: a newly discovered 'Great Barrier Reef'. Anaesthesist 2008; 57:959-969.
23. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006; (176 Pt 2):1-40.
24. Chappell D, Jacob M, Paul O, et al. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo, but not in culture. Circ Res (in press). The first visualization of the human endothelial glycocalyx shows significant differences in the thickness of this structure on umbilical cells ex vivo and in vitro.
25. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007; 73:575-586.
26. Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across nonfenestrated rat microvessels. J Physiol 2004; 557:889-907.
27. Hu X, Weinbaum S. A new view of Starling's hypothesis at the microstructural level. Microvasc Res 1999; 58:281-304.
28. Michel CC. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 1997; 82:1-30.
29. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid therapy. Anesthesiology 2008; 109:723-740. This review combines common knowledge with clinical research results and new physiological insights concerning the vascular barrier, explaining and underlining the importance of the third space providing a rational approach to perioperative fluid therapy.
30. Jacob M, Chappell D, Rehm M. Third space: fact or fiction? Best Pract Res Clin Anaesthesiol (in press).
31. Seghaye MC, Grabitz RG, Duchateau J, et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 112:687-697.
32. Nurnberger W, Michelmann I, Petrik K, et al. Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation. Ann Hematol 1993; 67:17-21.
33. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896-1906.
34. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55:480-486.
35. Nelson A, Berkestedt I, Schmidtchen A, et al. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008; 30:623-627. The authors show a positive correlation of the severity of sepsis with mortality and a deterioration of the endothelial glycocalyx.
36. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008; 26:711-715.
37. Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104:78-89.
38. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 2000; 101:1500-1502.
39. Chappell D, Jacob M, Hofmann-Kiefer K, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107:776-784.
40. Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Adv Immunol 2007; 95:167-255.
41. Chappell D, Jacob M, Rehm M, et al. Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008; 389:79-82.
42. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000; 279:H2815-H2823.
43. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68:729-777.
44. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29:572-576.
45. Nieuwdorp M, Meuwese MC, Mooij HL, et al. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 2008; 202:296-303. This clinical trial shows the impact of TNF-α on the integrity of the glycocalyx in humans.
46. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994; 94:2077-2083.
47. Matsuda M, Hattori Y. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 2007; 43:117-137.
48. Cain SM, Curtis SE. Experimental models of pathologic oxygen supply dependency. Crit Care Med 1991; 19:603-612.
49. Vallet B, Lund N, Curtis SE, et al. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994; 76:793-800.
50. Richard C. Tissue hypoxia. How to detect, how to correct, how to prevent? Intensive Care Med 1996; 22:1250-1257.
51. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9 (Suppl 4):S13-S19.
52. Walley KR, Lukacs NW, Standiford TJ, et al. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996; 64:4733-4738.
53. Humer MF, Phang PT, Friesen BP, et al. Heterogeneity of gut capillary transit times and impaired gut oxygen extraction in endotoxemic pigs. J Appl Physiol 1996; 81:895-904.
54. Cabrales P, Vazquez BY, Tsai AG, Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 2007; 102:2251-2259.
55. Nakajima Y, Baudry N, Duranteau J, Vicaut E. Microcirculation in intestinal villi: a comparison between hemorrhagic and endotoxin shock. Am J Respir Crit Care Med 2001; 164:1526-1530.
56. Poeze M. Tissue-oxygenation assessment using near-infrared spectroscopy during severe sepsis: confounding effects of tissue edema on StO2 values. Intensive Care Med 2006; 32:788-789.
57. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001; 95:849-856.
58. Jacob M, Chappell D, Rehm M. Clinical update: perioperative fluid management. Lancet 2007; 369:1984-1986.
59. Marx G, Schuerholz T, Reinhart K. Fluid management in sepsis: colloids or crystalloids? In: Yearbook of intensive care and emergency medicine. Heidelberg: Springer-Verlag; 2007. pp. 563-573.
60. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256.
61. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124.